ProAssurance (NYSE:PRA) Issues Quarterly Earnings Results, Beats Estimates By $0.19 EPS

ProAssurance (NYSE:PRA) issued its quarterly earnings results on Monday. The insurance provider reported $0.36 EPS for the quarter, topping the consensus estimate of $0.17 by $0.19, Zacks reports. ProAssurance had a net margin of 3.71% and a return on equity of 2.65%.

ProAssurance Stock Up 0.2 %

Shares of ProAssurance stock traded up $0.03 during midday trading on Monday, reaching $14.02. 393,523 shares of the company’s stock traded hands, compared to its average volume of 186,591. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.28 and a current ratio of 0.28. ProAssurance has a 52 week low of $10.76 and a 52 week high of $17.79. The company’s 50 day simple moving average is $15.19 and its 200 day simple moving average is $15.01. The company has a market cap of $717.21 million, a price-to-earnings ratio of 16.89 and a beta of 0.27.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Piper Sandler lowered shares of ProAssurance from an “overweight” rating to a “neutral” rating and set a $18.00 price objective on the stock. in a report on Monday, November 11th. StockNews.com upgraded ProAssurance from a “hold” rating to a “buy” rating in a research report on Thursday, December 26th. Finally, Truist Financial lifted their price objective on shares of ProAssurance from $14.00 to $18.00 and gave the company a “hold” rating in a research report on Tuesday, November 12th.

ProAssurance Company Profile

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.